Search
WAVE Life Sciences Ltd
WVEAdd to Watchlist
5.510USD
-0.250-4.34%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.09BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of WAVE Life Sciences Ltd is 8.63, ranking 92 out of 385 in the Biotechnology & Medical Research industry. The average price target is 23.00, with a high of 36.00 and a low of 12.00.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
20.813
Target Price
+277.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
WAVE Life Sciences Ltd
WVE
16
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is WAVE Life Sciences Ltd's expected revenue for the next quarter?
WAVE Life Sciences Ltd's expected revenue is 6.23M.
What is WAVE Life Sciences Ltd's price target?
Analysts forecast that WAVE Life Sciences Ltd's price target is USD 23.00, with the highest forecast at USD 36.00 and the lowest forecast at USD 12.00.
How have WAVE Life Sciences LtdWVE's recent earnings per share performed?
The market expectation was USD -0.34, while WAVE Life Sciences LtdWVE's earnings per share (EPS) for the previous quarter was USD -0.13. EPS for the next quarter is expected at USD -0.32.
What is the analyst rating for WAVE Life Sciences Ltd?
Based on the ratings of WAVE Life Sciences Ltd's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.